Abstract 19032: GLP-1 Receptor Agonists Added to Statin Therapy and Cardiovascular Outcomes in Patients with Atherosclerotic Cardiovascular Disease and Obesity
Background: Statins reduce cardiovascular events in atherosclerotic cardiovascular disease (ASCVD), yet residual risk remains high in patients with obesity. Whether adding a GLP-1 receptor agonist (GLP-1 RA) to statin therapy further reduces mortality, myocardial infarction (MI), and ischemic stroke in this populati...